UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
DAWN holding history
Day One Biopharmaceuticals, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DAWN overviewAll 13F holders of DAWNFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −2,305,123−100.0% | Sold out | Holders |
| Q1 2026 | 2,305,123 | $49.4M | <0.1% | +2,134,395+1,250.2% | Added | Holders |
| Q4 2025 | 170,728 | $1.59M | <0.1% | −38,989−18.6% | Reduced | Holders |
| Q3 2025 | 209,717 | $1.48M | <0.1% | +120,242+134.4% | Added | Holders |
| Q2 2025 | 89,475 | $581.6K | <0.1% | −34,701−27.9% | Reduced | Holders |
| Q1 2025 | 124,176 | $984.7K | <0.1% | +59,949+93.3% | Added | Holders |
| Q4 2024 | 64,227 | $813.8K | <0.1% | −50,410−44.0% | Reduced | Holders |
| Q3 2024 | 114,637 | $1.60M | <0.1% | +44,554+63.6% | Added | Holders |
| Q2 2024 | 70,083 | $965.7K | <0.1% | −93,935−57.3% | Reduced | Holders |
| Q1 2024 | 164,018 | $2.71M | <0.1% | +37,378+29.5% | Added | Holders |
| Q4 2023 | 126,640 | $1.85M | <0.1% | +102,759+430.3% | Added | Holders |
| Q3 2023 | 23,881 | $293.0K | <0.1% | +11,338+90.4% | Added | Holders |
| Q2 2023 | 12,543 | $149.8K | <0.1% | −57,322−82.0% | Reduced | Holders |
| Q1 2023 | 69,865 | $934.1K | <0.1% | −59,992−46.2% | Reduced | Holders |
| Q4 2022 | 129,857 | $2.79M | <0.1% | +108,251+501.0% | Added | Holders |
| Q3 2022 | 21,606 | $432.0K | <0.1% | +17,755+461.0% | Added | Holders |
| Q2 2022 | 3,851 | $69.0K | <0.1% | +3,851 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −6,103−100.0% | Sold out | Holders |
| Q4 2021 | 6,103 | $103.0K | <0.1% | +6,044+10,244.1% | Added | Holders |
| Q3 2021 | 59 | $1.00K | <0.1% | +59 | New | Holders |